Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers

We began analyzing https://link.springer.com/article/10.1007/s10549-012-1977-9, but it redirected us to https://link.springer.com/article/10.1007/s10549-012-1977-9. The analysis below is for the second page.

Title[redir]:
Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer | Breast Cancer Research and Treatment
Description:
Anti-angiogenesis targeting VEGFR-2 has been considered as an important strategy for cancer therapy. Ellagic acid is a naturally existing polyphenol widely found in fruits and vegetables. It was reported that ellagic acid interfered with some angiogenesis-dependent pathologies. Yet the mechanisms involved were not fully understood. Thus, we analyzed its anti-angiogenesis effects and mechanisms on human breast cancer utilizing in-vitro and in-vivo methodologies. The in-silico analysis was also carried out to further analyze the structure-based interaction between ellagic acid and VEGFR-2. We found that ellagic acid significantly inhibited a series of VEGF-induced angiogenesis processes including proliferation, migration, and tube formation of endothelial cells. Besides, it directly inhibited VEGFR-2 tyrosine kinase activity and its downstream signaling pathways including MAPK and PI3K/Akt in endothelial cells. Ellagic acid also obviously inhibited neo-vessel formation in chick chorioallantoic membrane and sprouts formation of chicken aorta. Breast cancer xenografts study also revealed that ellagic acid significantly inhibited MDA-MB-231 cancer growth and P-VEGFR2 expression. Molecular docking simulation indicated that ellagic acid could form hydrogen bonds and aromatic interactions within the ATP-binding region of the VEGFR-2 kinase unit. Taken together, ellagic acid could exert anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.

Matching Content Categories {📚}

  • Environment
  • Science
  • Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 80,473,390 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

ellagic, acid, vegfr, cancer, cells, article, endothelial, vegf, breast, angiogenesis, google, scholar, pubmed, huvecs, effects, cas, signaling, kinase, growth, assay, cell, fig, tumor, domain, treatment, proliferation, formation, activity, vivo, antiangiogenesis, found, concentrations, control, including, significantly, mice, results, inhibited, downstream, model, chick, vascular, medium, migration, inhibit, showed, study, tyrosine, pvegfr, molecular,

Topics {✒️}

jian-gang shen & jian-ping chen vascular endothelial-growth-factor receptor-2 full size image jian-ping chen mda-mb-231 cell line mda-mb-231 xenograft model possess anti-cancer properties article download pdf strong π–π interactions avidin–biotin–hrp complex existing endothelium-lined vessels including p-erk/erk inhibited neo-vessel formation exerts anti-angiogenesis effects hai-bin luo mba-md-231 tumor growth suppress tumor-induced angiogenesis 3 mg/ml cortisone acetate de-po yang mba-md-231 tumor volumes mda-mb-231 xenografts sun yat-sen university values represent means ± sd dose dependently suppressed exert anti-angiogenesis effects pbs-soaked cotton swab vitro anti-proliferative activities poly-glu-tyr substrate dcfh-da staining assay serum-free medium supplemented full access fresh serum-free medium dose dependently suppress vivo anti-angiogenesis effects receptor tyrosine kinases multiple molecular targets atp-binding region lies 20 ng/ml human vegf yu-ling chen ellagic acid-treated group dietary-derived phenolic compound support tumor growth deparaffinized tumor sections vegfr-2/ellagic acid complex ellagic acid/vegfr-2 complex vegf-stimulated p-vegfr2 decreased mmps activity percent kinase activity ligand-binding site based multiple signal pathways

Questions {❓}

  • Miller KD (2004) Recent translational research: antiangiogenic therapy for breast cancer—where do we stand?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer
         description:Anti-angiogenesis targeting VEGFR-2 has been considered as an important strategy for cancer therapy. Ellagic acid is a naturally existing polyphenol widely found in fruits and vegetables. It was reported that ellagic acid interfered with some angiogenesis-dependent pathologies. Yet the mechanisms involved were not fully understood. Thus, we analyzed its anti-angiogenesis effects and mechanisms on human breast cancer utilizing in-vitro and in-vivo methodologies. The in-silico analysis was also carried out to further analyze the structure-based interaction between ellagic acid and VEGFR-2. We found that ellagic acid significantly inhibited a series of VEGF-induced angiogenesis processes including proliferation, migration, and tube formation of endothelial cells. Besides, it directly inhibited VEGFR-2 tyrosine kinase activity and its downstream signaling pathways including MAPK and PI3K/Akt in endothelial cells. Ellagic acid also obviously inhibited neo-vessel formation in chick chorioallantoic membrane and sprouts formation of chicken aorta. Breast cancer xenografts study also revealed that ellagic acid significantly inhibited MDA-MB-231 cancer growth and P-VEGFR2 expression. Molecular docking simulation indicated that ellagic acid could form hydrogen bonds and aromatic interactions within the ATP-binding region of the VEGFR-2 kinase unit. Taken together, ellagic acid could exert anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.
         datePublished:2012-02-21T00:00:00Z
         dateModified:2012-02-21T00:00:00Z
         pageStart:943
         pageEnd:955
         license:https://creativecommons.org/licenses/by-nc/2.0
         sameAs:https://doi.org/10.1007/s10549-012-1977-9
         keywords:
            Ellagic acid
            Anti-angiogenesis
            VEGF/VEGFR2
            Molecular docking
            Breast cancer
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig6_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:134
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Neng Wang
               affiliation:
                     name:The University of Hong Kong
                     address:
                        name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhi-Yu Wang
               affiliation:
                     name:The University of Hong Kong
                     address:
                        name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sui-Lin Mo
               affiliation:
                     name:Sun Yat-Sen University
                     address:
                        name:The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tjing Yung Loo
               affiliation:
                     name:The University of Hong Kong
                     address:
                        name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dong-Mei Wang
               affiliation:
                     name:Sun Yat-Sen University
                     address:
                        name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hai-Bin Luo
               affiliation:
                     name:Sun Yat-Sen University
                     address:
                        name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:De-Po Yang
               affiliation:
                     name:Sun Yat-Sen University
                     address:
                        name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu-Ling Chen
               affiliation:
                     name:The University of Sydney
                     address:
                        name:Faculty of Pharmacy, The University of Sydney, Sydney, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jian-Gang Shen
               affiliation:
                     name:The University of Hong Kong
                     address:
                        name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jian-Ping Chen
               affiliation:
                     name:The University of Hong Kong
                     address:
                        name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer
      description:Anti-angiogenesis targeting VEGFR-2 has been considered as an important strategy for cancer therapy. Ellagic acid is a naturally existing polyphenol widely found in fruits and vegetables. It was reported that ellagic acid interfered with some angiogenesis-dependent pathologies. Yet the mechanisms involved were not fully understood. Thus, we analyzed its anti-angiogenesis effects and mechanisms on human breast cancer utilizing in-vitro and in-vivo methodologies. The in-silico analysis was also carried out to further analyze the structure-based interaction between ellagic acid and VEGFR-2. We found that ellagic acid significantly inhibited a series of VEGF-induced angiogenesis processes including proliferation, migration, and tube formation of endothelial cells. Besides, it directly inhibited VEGFR-2 tyrosine kinase activity and its downstream signaling pathways including MAPK and PI3K/Akt in endothelial cells. Ellagic acid also obviously inhibited neo-vessel formation in chick chorioallantoic membrane and sprouts formation of chicken aorta. Breast cancer xenografts study also revealed that ellagic acid significantly inhibited MDA-MB-231 cancer growth and P-VEGFR2 expression. Molecular docking simulation indicated that ellagic acid could form hydrogen bonds and aromatic interactions within the ATP-binding region of the VEGFR-2 kinase unit. Taken together, ellagic acid could exert anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.
      datePublished:2012-02-21T00:00:00Z
      dateModified:2012-02-21T00:00:00Z
      pageStart:943
      pageEnd:955
      license:https://creativecommons.org/licenses/by-nc/2.0
      sameAs:https://doi.org/10.1007/s10549-012-1977-9
      keywords:
         Ellagic acid
         Anti-angiogenesis
         VEGF/VEGFR2
         Molecular docking
         Breast cancer
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-1977-9/MediaObjects/10549_2012_1977_Fig6_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:134
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Neng Wang
            affiliation:
                  name:The University of Hong Kong
                  address:
                     name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhi-Yu Wang
            affiliation:
                  name:The University of Hong Kong
                  address:
                     name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sui-Lin Mo
            affiliation:
                  name:Sun Yat-Sen University
                  address:
                     name:The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tjing Yung Loo
            affiliation:
                  name:The University of Hong Kong
                  address:
                     name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dong-Mei Wang
            affiliation:
                  name:Sun Yat-Sen University
                  address:
                     name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hai-Bin Luo
            affiliation:
                  name:Sun Yat-Sen University
                  address:
                     name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:De-Po Yang
            affiliation:
                  name:Sun Yat-Sen University
                  address:
                     name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu-Ling Chen
            affiliation:
                  name:The University of Sydney
                  address:
                     name:Faculty of Pharmacy, The University of Sydney, Sydney, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jian-Gang Shen
            affiliation:
                  name:The University of Hong Kong
                  address:
                     name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jian-Ping Chen
            affiliation:
                  name:The University of Hong Kong
                  address:
                     name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:134
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Hong Kong
      address:
         name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:The University of Hong Kong
      address:
         name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:Sun Yat-Sen University
      address:
         name:The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
         type:PostalAddress
      name:The University of Hong Kong
      address:
         name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:Sun Yat-Sen University
      address:
         name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
         type:PostalAddress
      name:Sun Yat-Sen University
      address:
         name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
         type:PostalAddress
      name:Sun Yat-Sen University
      address:
         name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
         type:PostalAddress
      name:The University of Sydney
      address:
         name:Faculty of Pharmacy, The University of Sydney, Sydney, Australia
         type:PostalAddress
      name:The University of Hong Kong
      address:
         name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:The University of Hong Kong
      address:
         name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Neng Wang
      affiliation:
            name:The University of Hong Kong
            address:
               name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Zhi-Yu Wang
      affiliation:
            name:The University of Hong Kong
            address:
               name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Sui-Lin Mo
      affiliation:
            name:Sun Yat-Sen University
            address:
               name:The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Tjing Yung Loo
      affiliation:
            name:The University of Hong Kong
            address:
               name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Dong-Mei Wang
      affiliation:
            name:Sun Yat-Sen University
            address:
               name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Hai-Bin Luo
      affiliation:
            name:Sun Yat-Sen University
            address:
               name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:De-Po Yang
      affiliation:
            name:Sun Yat-Sen University
            address:
               name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Yu-Ling Chen
      affiliation:
            name:The University of Sydney
            address:
               name:Faculty of Pharmacy, The University of Sydney, Sydney, Australia
               type:PostalAddress
            type:Organization
      name:Jian-Gang Shen
      affiliation:
            name:The University of Hong Kong
            address:
               name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Jian-Ping Chen
      affiliation:
            name:The University of Hong Kong
            address:
               name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
      name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
      name:The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
      name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
      name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
      name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
      name:School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
      name:Faculty of Pharmacy, The University of Sydney, Sydney, Australia
      name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
      name:School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

External Links {🔗}(266)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
5.69s.